Alerts will be sent to your verified email
Verify EmailSHUKRAPHAR
|
Shukra Pharma
|
Lincoln Pharma
|
NGL Fine-Chem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.12 % | 15.1 % | 18.68 % |
|
5yr average Equity Multiplier
|
2.02 | 1.26 | 1.37 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 0.82 | 1.03 |
|
5yr Avg Net Profit Margin
|
13.41 % | 14.59 % | 12.56 % |
|
Price to Book
|
15.56 | 1.87 | 4.51 |
|
P/E
|
63.39 | 15.21 | 38.56 |
|
5yr Avg Cash Conversion Cycle
|
-114.74 Days | -6.41 Days | 24.74 Days |
|
Inventory Days
|
40.87 Days | 43.91 Days | 47.94 Days |
|
Days Receivable
|
186.38 Days | 91.75 Days | 84.83 Days |
|
Days Payable
|
342.97 Days | 128.38 Days | 83.75 Days |
|
5yr Average Interest Coverage Ratio
|
23.9 | 63.13 | 25.7 |
|
5yr Avg ROCE
|
14.63 % | 19.81 % | 24.83 % |
|
5yr Avg Operating Profit Margin
|
20.24 % | 18.35 % | 18.08 % |
|
5 yr average Debt to Equity
|
0.23 | 0.0 | 0.16 |
|
5yr CAGR Net Profit
|
119.04 % | 5.76 % | -18.08 % |
|
5yr Average Return on Assets
|
8.68 % | 11.92 % | 13.76 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.96 % | 49.78 % | 72.74 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.06 % | 2.78 % | -0.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shukra Pharma
|
Lincoln Pharma
|
NGL Fine-Chem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|